Show Notes
What happens when AI stops simply giving answers and starts producing proofs a computer can verify?
In this episode of The Neuron, Corey Noles and Grant Harvey talk with Tudor Achim, Co-Founder and CEO of Harmonic, the company behind Aristotle — a formal reasoning system built to generate machine-checkable mathematical proofs. Tudor explains why math may be the clearest test case for moving AI from “trust me” to “check me,” and why formal verification could matter far beyond Olympiad benchmarks.
They discuss what “mathematical superintelligence” actually means, why Tudor thinks solving a Millennium Prize problem would be a meaningful threshold, and how Lean-based proofs could change the way mathematicians collaborate. They also explore Aristotle’s real-world use cases, from open math problems to verified software, chip design, scientific computing, and the future of AI-assisted discovery.
Plus: why Tudor thinks formal math has reached a “zero to one” moment, why specs may be the bottleneck in verified software, and why humans still need to direct the questions AI systems try to solve.
Subscribe to The Neuron and sign up for The Neuron Daily at theneuron.ai.
More from The Neuron: AI Explained
Neurosurgeon-scientists Alex Ksendzovsky and Jon Pomeraniec explain how The Biological Computing Company uses living neurons as a research platform for AI. Their team grows roughly 150,000 cells on a 4,096-electrode array, sends in patterns such as handwritten digits, records how the neurons respond, and models useful computational behaviors in software. They say those neuron-inspired techniques are already helping GPU-based video-generation systems run about 5x faster with roughly 80% lower inference cost, while their longer-term work explores robots, world models, and real-time biological compute.
OpenAI just dropped 20+ announcements at DevDay 2026, so... yeah, we have some things to talk about. 😺
Runway co-founder Anastasis Germanidis explains Solaris, an “interface world model” that generates software frame by frame instead of rendering a traditional interface from HTML and CSS.
OpenAI DevDay 2026 is here, and we’re hosting a watch party to watch the keynote LIVE.
Corey and Grant sit down with Mammoth Biosciences co-founder and CEO Dr. Trevor Martin to explain how CRISPR is moving from a laboratory tool toward one-time medicines.